Healthcare Services
-
Carl Icahn Ends Second Proxy Fight with Illumina (ILMN) Board
Activist investor Carl Icahn spares Illumina a second proxy contest, but continues lawsuit, leaving retail investors curious about board dynamics...
-
Obesity Treatment Demand Spurs Novo Factory Buyout
Novo (NVO stock) expands manufacturing with a strategic $11B purchase, aiming to meet the surging demand for obesity treatments.
-
Beauty Health (SKIN Stock) Faces Market Turbulence, CEO Departs
Beauty Health's stock drops 64%, showing the market's reaction to its financial and operational struggles and highlighting risks and opportunities...
-
Microsoft's Health Tech Push Opens New Investment Avenues
Microsoft's new healthcare tools could revolutionize the sector. Learn how these changes offer fresh investment opportunities in tech and...
-
What SmileDirectClub's Fall Means for Retail Investors
SmileDirectClub's bankruptcy offers valuable lessons for retail investors. From assessing risk in high-growth startups to exploring new investment...
-
Jabil (JBL) Shifts Focus with $2.2 Billion Mobility Divestment
Jabil Inc. divests its Mobility unit in a $2.2 billion deal with BYD Electronic. The move aims to boost shareholder value and reinvest in...
-
IPO Outlook: MGRX, YGF, GDHG
This week's IPOs include Chinese theme park operator Golden Heaven, erectile dysfunction specialists Mangoceuticals and an emerging health food...
-
Daily Stock Watch: Axonics (AXNX) Share Price Target Raised
Piper Sandler raises AXNX share price target. Will this fast-growing health stock win market share over its competitors and bring shareholder returns?
-
Is Regen BioPharma a Good Investment?
Regen BioPharma recently filed a patent related to a mRNA cancer immunotherapeutic vaccine. Does the market growth potential make RGBP a good...
-
As Myocarditis Debate Rages On, Heart Disease Cases Mount
Few had heard of myocarditis before the pandemic, but now it’s a serious worry making global headlines. One company is hoping to treat it.
-
Patients Welcome Relief from Particle Pollution Harm
Poor air quality, in part caused by issues surrounding climate change, has forced these healthcare companies into looking at ways to combat heart...
-
Breakthroughs In Treating Killer Diseases Could Lengthen Life
The healthcare industry is fighting back against the world's top killer diseases, aiming to prolong lives and provide better standards of care for...
-
As Health Problems Mount Patients Welcome New Treatments
Healthcare is changing, as more and more diseases pose a growing concern for society and the companies trying to cure them.
-
Tackling Recurring Health Conditions Offers Hope to Patients
Find out more about how Merck (NYSE: MRK), Bio-Techne Corporation (NASDAQ: TECH), Natera (NASDAQ: NTRA) and Cardiol Therapeutics (NASDAQ: CRDL)...
-
The Healthcare Sector is About More Than Just COVID
Our 'Key Themes For 2022' is designed to help you identify and capitalise on the areas to watch out for. Here we have healthcare.
-
Investing in Genomics
Ongoing growth in genomics investing looks promising, as connections between genetics and diseases are explored. Scientific breakthroughs are...